News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
168 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21087)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (168)
2 (76)
4 (3)
5 (150)
6 (144)
7 (139)
8 (146)
9 (72)
10 (4)
11 (1)
12 (157)
13 (167)
14 (125)
15 (111)
16 (54)
17 (4)
19 (20)
20 (49)
21 (57)
22 (62)
23 (38)
25 (1)
26 (79)
27 (106)
28 (97)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
25
26
27
28
Deals
Sverica Capital Management Announces Recapitalization of Resonetics With GTCR
The transaction is expected to close in early February.
February 1, 2018
·
3 min read
Teva Completes Amendment to Credit Facilities on February 1, 2018
Teva Pharmaceutical Industries Ltd., today announced amendments to its USD and JPY term loan and revolving credit facilities, providing the company greater flexibility in its financial leverage ratio covenants.
February 1, 2018
·
7 min read
Business
Dynatronics Welcomes Skyler Black as Its New Corporate Controller, Further Strengthens Its Finance Team
Dynatronics Corporation today announced the appointment of Skyler Black as Corporate Controller, effective January 22, 2018.
February 1, 2018
·
2 min read
Biotech Bay
HeartFlow Announces More Than 185 Million Patients Have Access to Non-Invasive HeartFlow FFRct Analysis
HeartFlow, Inc. today announced that seven new commercial payers issued positive medical policies covering the use of the HeartFlow FFRct Analysis following a coronary computed tomography angiogram (CCTA).
February 1, 2018
·
3 min read
Shire plc: Total Voting Rights - February 1, 2018
As at January 31, 2018, the Company’s issued ordinary share capital comprised 910,039,956 ordinary shares of 5 pence each with voting rights and a further 7,357,283 ordinary shares held in treasury.
February 1, 2018
·
1 min read
Biotech Bay
CareDx: First Patient Enrolled in AlloSure Registry
Innovative AlloSure registry brings standardization to transplant centers.
February 1, 2018
·
2 min read
Business
Bayer Hires Dan Childs of ABC News as Director of U.S. External Communications
Bayer announced today that Dan Childs, award-winning medical journalist and Managing Editor of the ABC News Medical Unit, is joining the company as Director of External Communications responsible primarily for U.S. Media Relations.
February 1, 2018
·
4 min read
Business
INSYS Therapeutics Appoints Vaseem Mahboob to Board of Directors
A former GE Healthcare finance executive and the current chief financial officer of Endologix, Inc., Mr. Mahboob will also serve on the board’s audit committee.
February 1, 2018
·
2 min read
Pharm Country
Mylan Expands Access to HIV/AIDS Medicines with Launch of First Generic Sustiva Tablets
Mylan today announced the U.S. launch of Efavirenz Tablets USP, 600 mg, the first generic version of Bristol-Myers Squibb’s Sustiva
February 1, 2018
·
5 min read
Business
Aytu BioScience to Report Fiscal Second Quarter 2018 Results and Business Update
The Company will review recent accomplishments and provide an overview of its business and growth strategy.
February 1, 2018
·
4 min read
Previous
5 of 17
Next